Seunghyun Lee1, Jung Hoon Kim2,3, Jae Hwan Lee1, Jeong Hwa Lee1, Joon Koo Han1,4. 1. Department of Radiology, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul, 110-744, Korea. 2. Department of Radiology, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul, 110-744, Korea. jhkim2008@gmail.com. 3. Institute of Radiation Medicine, Seoul National University College of Medicine, Seoul, Korea. jhkim2008@gmail.com. 4. Institute of Radiation Medicine, Seoul National University College of Medicine, Seoul, Korea.
Abstract
PURPOSE: We investigated the changes of tissue oxygen saturation (sO2) in sorafenib-treated HCC (hepatocelluar carcinoma) mouse models using photoacoustic imaging (PI). MATERIALS AND METHODS: Nude mice, implanted with human HCC (HepG2-RFP) cells in the liver, were randomised to the sorafenib-treated group (n = 21) or the control group (n = 20). Tumour volume and sO2 were measured by PI at baseline and then one week later, and radiant efficiency (RE) and therapeutic response were analysed by fluorescence imaging and histologic analysis. RESULTS: Sorafenib was effective in treating HCC by evaluating necrotic fraction, apoptosis index, and microvessel density (MVD). One week after treatment, the sO2 of HCC and residual healthy liver tissue decreased, and the hypoxia inducible factor-1α (HIF-1α) protein expression of HCC increased, correlating with the apoptosis index. The ΔsO2 in HCC showed a significantly positive correlation with the necrotic fraction and the apoptosis index of tumour and a negative correlation with the MVD of tumour. CONCLUSION: Sorafenib treatment results in changes of sO2 in HCC and liver parenchyma and induces the accumulation of HIF-1α by hypoxic environment. sO2 as measured by PI, can be a useful marker for non-invasive monitoring of the therapeutic response in orthotopic HCC mouse models. KEY POINTS: • Hypoxia is a characteristic feature of the tumour microenvironment • It is important to monitor sO 2 in HCC during sorafenib treatment • PI is useful for non-invasive monitoring of sO 2 in HCC. • ΔsO 2 in HCC showed a significantly correlation with tumour response.
PURPOSE: We investigated the changes of tissue oxygen saturation (sO2) in sorafenib-treated HCC (hepatocelluar carcinoma) mouse models using photoacoustic imaging (PI). MATERIALS AND METHODS:Nude mice, implanted with human HCC (HepG2-RFP) cells in the liver, were randomised to the sorafenib-treated group (n = 21) or the control group (n = 20). Tumour volume and sO2 were measured by PI at baseline and then one week later, and radiant efficiency (RE) and therapeutic response were analysed by fluorescence imaging and histologic analysis. RESULTS:Sorafenib was effective in treating HCC by evaluating necrotic fraction, apoptosis index, and microvessel density (MVD). One week after treatment, the sO2 of HCC and residual healthy liver tissue decreased, and the hypoxia inducible factor-1α (HIF-1α) protein expression of HCC increased, correlating with the apoptosis index. The ΔsO2 in HCC showed a significantly positive correlation with the necrotic fraction and the apoptosis index of tumour and a negative correlation with the MVD of tumour. CONCLUSION:Sorafenib treatment results in changes of sO2 in HCC and liver parenchyma and induces the accumulation of HIF-1α by hypoxic environment. sO2 as measured by PI, can be a useful marker for non-invasive monitoring of the therapeutic response in orthotopic HCC mouse models. KEY POINTS: • Hypoxia is a characteristic feature of the tumour microenvironment • It is important to monitor sO 2 in HCC during sorafenib treatment • PI is useful for non-invasive monitoring of sO 2 in HCC. • ΔsO 2 in HCC showed a significantly correlation with tumour response.
Authors: Andrew Needles; Andrew Heinmiller; John Sun; Catherine Theodoropoulos; David Bates; Desmond Hirson; Melissa Yin; F Stuart Foster Journal: IEEE Trans Ultrason Ferroelectr Freq Control Date: 2013-05 Impact factor: 2.725
Authors: Yunching Chen; Yuhui Huang; Thomas Reiberger; Annique M Duyverman; Peigen Huang; Rekha Samuel; Lotte Hiddingh; Sylvie Roberge; Christina Koppel; Gregory Y Lauwers; Andrew X Zhu; Rakesh K Jain; Dan G Duda Journal: Hepatology Date: 2014-02-18 Impact factor: 17.425
Authors: Scott M Wilhelm; Christopher Carter; Liya Tang; Dean Wilkie; Angela McNabola; Hong Rong; Charles Chen; Xiaomei Zhang; Patrick Vincent; Mark McHugh; Yichen Cao; Jaleel Shujath; Susan Gawlak; Deepa Eveleigh; Bruce Rowley; Li Liu; Lila Adnane; Mark Lynch; Daniel Auclair; Ian Taylor; Rich Gedrich; Andrei Voznesensky; Bernd Riedl; Leonard E Post; Gideon Bollag; Pamela A Trail Journal: Cancer Res Date: 2004-10-01 Impact factor: 13.312
Authors: Mohamed A Naser; Diego R T Sampaio; Nina M Munoz; Cayla A Wood; Trevor M Mitcham; Wolfgang Stefan; Konstantin V Sokolov; Theo Z Pavan; Rony Avritscher; Richard R Bouchard Journal: IEEE Trans Med Imaging Date: 2018-09-10 Impact factor: 10.048